Project Grant R21DE034542

Award Date 9/17/24
Completion Date 9/16/26
Dollars Obligated $429K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $442,750 to Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to conduct research on the interactions between the bacterium Fusobacterium nucleatum and oral squamous cell carcinomas. The key objectives of this 2-year project are to: 1) identify tumor cell determinants that influence...
This Project Grant award of $310,500.00 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) federal grant program, supports a comparative experimental evolution study on gene essentiality in the oral bacteria Streptococcus sanguinis and S. mutans. The research aims to categorize the essential genes in S. mutans, identify and classify suppressor mutations for its evolvable essential genes, and compare the findings...
This $431,750 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) supports research to decipher the mechanisms by which two proteins, AAFLP-1 and AADCUB, regulate the production of exopolysaccharide (PNAG) in the oral bacterium Aggregatibacter actinomycetemcomitans. The research aims to investigate how these two proteins, which are unique to A. actinomycetemcomitans, independently...
This Project Grant award of $858,000 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research to explore the mechanisms by which the bacterium Veillonella inhibits the hemolytic activity of the periodontal pathogen Porphyromonas gingivalis. The research aims to: 1) investigate how Veillonella's heme production suppresses P. gingivalis' hemolysis, and 2) determine how P. gingivalis regulates...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $873,546 to the University of Texas Health Science Center at Houston to develop an "oral micro-drug factory" using engineered Limosilactobacillus reuteri bacteria to secrete the anti-inflammatory cytokine interleukin-10 (IL-10) for treating periodontitis. The goal is to locally administer the...
This Project Grant award, with a total funding amount of $234,000.00, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121). The goal of this project is to characterize the natural competence ability of oral Prevotella species and develop a genetic toolbox for detailed genetic studies of these bacteria. Specifically, the research aims to break the genetic tractability barrier within...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to investigate functional amyloid formation in the oral bacterium Streptococcus mutans. The total funding amount is $505,530 and the award period runs from September 16, 2024 to September 15, 2025. The key research objectives include: (1) exploring the relationships between S. mutans amyloid-forming...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund a systematic functional genomics analysis of the oral pathogen Streptococcus mutans. The $838,322 award, granted on Sep 24, 2024, will enable Arkansas State University to: Construct an arrayed and sequence-defined transposon mutant library for S. mutans to systematically identify infection-relevant genes. Study the...
This Project Grant award of $310,000.00 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) federal grant program, will fund research to identify natural products synthesized by Streptococcus mutans bacteria that can kill the pathogen Enterococcus faecalis. The research aims to determine if S. mutans biofilms producing these natural products can exclude E. faecalis from invading pre-formed biofilms and shape the...
This federal Project Grant award of $241,500.00 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) program, supports research to identify diffusible small molecules that regulate the replication of the bacterium Porphyromonas gingivalis (P. gingivalis). The research aims to establish the identity of growth-promoting cues produced by different strains of P. gingivalis and the bacterium Veillonella parvula that...

This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), funded under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research to study essential genes in the oral pathobiont Fusobacterium nucleatum. The $429,000 award to the University of Texas Health Science Center at Houston aims to investigate the molecular basis for the essentiality of the FomA gene and systematically identify other essential genes in F. nucleatum. The goal is to develop targeted, narrow-spectrum antibiotics to effectively treat F. nucleatum infections, which are linked to various health conditions beyond the oral cavity. The 2-year project period runs from September 2024 to September 2026. The research findings are expected to provide critical insights to enable the development of new antimicrobial treatments specifically targeting this significant oral pathogen.

Generated 7/1/25, 4:07 AM